Authors
Latest:
Treatment Options in RAI-refractory DTC in Second Line and BeyondLori Wirth, MD, discusses the role of cabozantinib in the second-line setting for patients with radioiodine-refractory differentiated thyroid cancer and reviews the results from the COSMIC-311 trial.
Latest:
Molecular Characterization and Treatment of Pancreatic Neuroendocrine TumorsONCOLOGY recently spoke with Ana Maria Cristina De Jesus-Acosta, MD, an assistant professor of oncology at Johns Hopkins University, about the molecular characterization and treatment of pancreatic neuroendocrine tumors.
Latest:
Taking a Patient-First Approach to Treatment in Chronic Lymphocytic LeukemiaAs developments in treatment options advance in chronic lymphocytic leukemia, Dr Pagel discusses the importance of finding a treatment for patients to deliver long-term outcomes that do not compromise tolerability.
Latest:
Multidisciplinary Team Is ‘Critical’ in Providing CAR T Therapy for Blood CancersTreatment with CAR T cells may allow patients with hematologic malignancies to recover more quickly compared with a transplant, says Andre Goy, MD.
Latest:
Breast Reconstruction in the Setting of Postmastectomy Radiotherapy: Controversies and DisparitiesBreast reconstruction improves quality of life, but providers must be aware of the risks and benefits of each reconstruction approach in the setting of postmastectomy radiotherapy.
Latest:
Breast Reconstruction in the Setting of Postmastectomy Radiotherapy: Controversies and DisparitiesBreast reconstruction improves quality of life, but providers must be aware of the risks and benefits of each reconstruction approach in the setting of postmastectomy radiotherapy.
Latest:
Next Generation of CAR-T Therapies in LymphomaExperts comment on the future of CAR T-cell therapy development and the use of dual CAR-T and CAR-T retreatment.
Latest:
Recurrent Small Cell Carcinoma of the Lung With Cutaneous Metastasis in BreastExperts present a case of recurrent small cell lung cancer presenting with a cutaneous metastatic nodule in the right breast.
Latest:
Samantha Jaglowski, MD, MPH, on Next Steps Regarding Tisagenlecleucel for Patients with DLBCLThe associate professor at The Ohio State University Comprehensive Cancer Center explained the goals for the future of the CAR T-cell therapy data in patients with DLBCL.
Latest:
Megan Kruse, MD, Discusses the Use of Biosimilars in Breast Cancer TreatmentThe hematology and medical oncology expert described the implementation of biosimilars into treating patients with breast cancer.
Latest:
Corey Speers, MD, PhD, Discusses Personalized Radiation Treatment and Genomic SignaturesThe assistant professor from the University of Michigan talked about personalizing radiation treatment in patients with breast cancer and how genomic signatures can be used to identify the radiation needs of patients.
Latest:
Nadine M. Tung, MD, Discusses Germline Testing in Patients with Breast CancerThe cancer risk and prevention expert discussed germline testing and the benefits it lends to patients with breast cancer.
Latest:
Bijal D. Shah, MD, on CAR T-cell therapy and mantle cell lymphomaBijal D. Shah, MD, discusses the progress made regarding CAR T-cell therapy and mantle cell lymphoma.
Latest:
Madelaine Kuiper, MSN, NP, Discusses Rapid Development of HER2-Targeted TherapiesThe nurse practitioner from UCLA Health spoke about the expanding treatment options in this setting.
Latest:
Simon Rule, MD, PhD, on Long-Term Outcomes with Ibrutinib Versus Prior Treatment RegimensThe expert hematologist from Plymouth University Medical Center discussed the long-term outcomes of patients receiving ibrutinib for mantle cell lymphoma at the ASH Annual Meeting and Exposition.
Latest:
Jeff P. Sharman, MD, on Results from the ELEVATE TN Study in CLLThe Willamette Valley Cancer Institute and Research Center expert talks about the results of the ELEVATE TN trial at the ASH Annual Meeting and Exposition.
Latest:
Diego Villa, MD, FRCPC, Discusses Bendamustine and Rituximab as Induction Therapy in MCLDiego Villa, MD, FRCPC, elaborated on the progress made with bendamustine and rituximab as induction therapy for transplant eligible and ineligible patients with mantle cell lymphoma.
Latest:
Courtney DiNardo, MD, MSCE, on Enasidenib Plus Azacitidine in Newly Diagnosed AMLCourtney DiNardo, MD, MSCE, elaborated on interim phase II results regarding enasibenib plus azacitidine in patients with newly diagnosed acute myeloid leukemia, and the results from the QUAZAR trial.
Latest:
Location, Location, Location: Approaches to Retroperitoneal Vascular LeiomyosarcomaSarcomas are relatively rare malignant tumors that arise from mesenchymal cells and therefore encompass a variety of histologies and can occur in any anatomic compartment. The incidence of sarcoma is estimated at 1% of all new cancer diagnoses in the United States annually. Approximately 15% of soft tissue sarcomas occur in the retroperitoneum, with about 1600 new retroperitoneal sarcoma cases diagnosed in the United States each year.
Latest:
Location, Location, Location: Approaches to Retroperitoneal Vascular LeiomyosarcomaSarcomas are relatively rare malignant tumors that arise from mesenchymal cells and therefore encompass a variety of histologies and can occur in any anatomic compartment. The incidence of sarcoma is estimated at 1% of all new cancer diagnoses in the United States annually. Approximately 15% of soft tissue sarcomas occur in the retroperitoneum, with about 1600 new retroperitoneal sarcoma cases diagnosed in the United States each year.
Latest:
Finding the Next Line of Treatment in MelanomaFor those with early-stage melanoma, surgery may be the only treatment needed. However, when melanoma has spread beyond the skin, additional treatments before or after surgery may be necessary.
Latest:
A 65-Year-Old Man With Back Pain and Imaging Findings of Spinal Cord CompressionMehmet S. Copur, MD, and colleagues examine the case of a 65-year-old who presented with back pain and a large T8 spinal mass, leading to a diagnosis of multiple myeloma with spinal cord compromise.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
Exploring the Future of ctDNA and Novel Treatment StrategiesPanelists offer concluding perspectives on the future role of circulating tumor DNA in colorectal cancer management.
Latest:
Joseph Kim, MD, on Liquid Biopsies as a Diagnostic for GI CancersThe chief of surgical oncology at the UK Markey Cancer Center discussed liquid biopsies and their potential importance for diagnosing gastric cancer.
Latest:
Synchronous Bilateral Lung Cancer With Discordant HistologyMedical oncologsts discuss the case of a 70-year old woman with synchronous multiple primary lung cancer.
